Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Pridopidine

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ferrer collaboration with Prilenia for Pridopidine deal
    Ferrer collaboration with Prilenia for Pridopidine deal

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250427034068/en/Ferrer-Enters-Into-a-Collaboration-and-License-Agreement-With-Prilenia-for-the-Commercialization-and-Co-Development-of-Pridopidine

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    We Enter into Collab & License Deal With Prilenia For Pridopidine
    We Enter into Collab & License Deal With Prilenia For Pridopidine

    28 Apr 2025

    // PRESS RELEASE

    https://www.ferrer.com/en/Ferrer-enters-into-a-collaboration-and-license-agreement-with-Prilenia-for-the-commercialization-and-co-development-of-Pridopidine

    PRESS RELEASE
    28 Apr 2025
    Share Share
    Prilenia: Huntington's, ALS Pridopidine Data At AAN 2024
    Prilenia: Huntington's, ALS Pridopidine Data At AAN 2024

    12 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240412355764/en

    BUSINESSWIRE
    12 Apr 2024
    Share Share
    Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease
    Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease

    12 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240311060274/en

    BUSINESSWIRE
    12 Mar 2024
    Share Share
    Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech
    Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech

    24 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230223005772/en

    BUSINESSWIRE
    24 Feb 2023
    Share Share
    Prilenia searches for positive signs in phase 2 ALS fail
    Prilenia searches for positive signs in phase 2 ALS fail

    23 Feb 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/prilenia-searches-positive-signs-als-treatment-fails-improve-disease-severity-phase-2

    Annalee Armstrong FIERCE BIOTECH
    23 Feb 2023
    Share Share